These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
795 related items for PubMed ID: 19055260
1. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy]. Straver ME, van Adrichem JC, Rutgers EJ, Rodenhuis S, Linn SC, Loo CE, Gilhuijs KG, Oldenburg HS, Wesseling J, Russell NS, Antonini N, Vrancken Peeters MT. Ned Tijdschr Geneeskd; 2008 Nov 15; 152(46):2519-25. PubMed ID: 19055260 [Abstract] [Full Text] [Related]
2. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients. Garimella V, Qutob O, Fox JN, Long ED, Chaturvedi A, Turnbull LW, Drew PJ. Eur J Surg Oncol; 2007 Mar 15; 33(2):157-61. PubMed ID: 17085007 [Abstract] [Full Text] [Related]
3. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, Gerber B, Eiermann W, Hilfrich J, Huober J, Jackisch C, Kaufmann M, Konecny GE, Denkert C, Nekljudova V, Mehta K, Loibl S. J Clin Oncol; 2012 May 20; 30(15):1796-804. PubMed ID: 22508812 [Abstract] [Full Text] [Related]
4. Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer: correlation of histology, hormone receptor status, Her2/Neu, and gross pathologic findings. Alvarado-Cabrero I, Alderete-Vázquez G, Quintal-Ramírez M, Patiño M, Ruíz E. Ann Diagn Pathol; 2009 Jun 20; 13(3):151-7. PubMed ID: 19433292 [Abstract] [Full Text] [Related]
5. Primary systemic therapy of breast cancer. Sachelarie I, Grossbard ML, Chadha M, Feldman S, Ghesani M, Blum RH. Oncologist; 2006 Jun 20; 11(6):574-89. PubMed ID: 16794237 [Abstract] [Full Text] [Related]
6. [Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]. Sinn HP, Schmid H, Junkermann H, Huober J, Leppien G, Kaufmann M, Bastert G, Otto HF. Geburtshilfe Frauenheilkd; 1994 Oct 20; 54(10):552-8. PubMed ID: 8001751 [Abstract] [Full Text] [Related]
14. Neoadjuvant chemotherapy for locally advanced breast cancer results in alterations in preoperative tumor marker status. Piper GL, Patel NA, Patel JA, Malay MB, Julian TB. Am Surg; 2004 Dec 20; 70(12):1103-6. PubMed ID: 15663054 [Abstract] [Full Text] [Related]
15. [Primary systemic therapy in breast cancer patients (2007-2010)]. Zapf I, Tizedes G, Pavlovics G, Kovács G, Kálmán E, Szalai G, Kövér E, Farkas R, Horváth OP. Magy Seb; 2011 Oct 20; 64(5):223-8. PubMed ID: 21997525 [Abstract] [Full Text] [Related]
17. Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors. Rouzier R, Mathieu MC, Sideris L, Youmsi E, Rajan R, Garbay JR, André F, Marsiglia H, Spielmann M, Delaloge S. Cancer; 2004 Sep 01; 101(5):918-25. PubMed ID: 15329898 [Abstract] [Full Text] [Related]
19. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer. Cho JH, Park JM, Park HS, Park S, Kim SI, Park BW. J Surg Oncol; 2013 Dec 01; 108(8):531-6. PubMed ID: 24115142 [Abstract] [Full Text] [Related]
20. Surgical complications of skin sparing mastectomy and immediate prosthetic reconstruction after neoadjuvant chemotherapy for invasive breast cancer. Donker M, Hage JJ, Woerdeman LA, Rutgers EJ, Sonke GS, Vrancken Peeters MJ. Eur J Surg Oncol; 2012 Jan 01; 38(1):25-30. PubMed ID: 21963981 [Abstract] [Full Text] [Related] Page: [Next] [New Search]